Adam, E., P. Kerkhofs, M. Mammerickx, A. Burny, R. Kettmann, and L. Willems. 1996. The CREB, ATF-1, and ATF-2 transcription factors from bovine leukemia virus-infected B lymphocytes activate viral expression. J. Virol. 70:1990-1999.
1a. Adam, E., P. Kerkhofs, M. Mammerickx, R. Kettmann, A. Burny, L. Droogmans, and L. Willems. 1994 Involvement of the cyclic AMP-responsive element-binding protein in bovine leukemia virus expression in vivo. J. Virol. 68:5845-5853
Baliga, V., and J. F. Ferrer. 1977. Expression of the bovine leukemia virus and its internal antigen in blood lymphocytes. Proc. Soc. Exp. Biol Med. 156:388-391
Brooks, P. A., J. K. Nyborg, and G. L. Cockerell. 1995. Identification of an NF-κB binding site in the bovine leukemia virus promoter J. Virol. 69:6005-6009.
Burny, A., C. Bruck, H. Chantrenne, Y. Cleuter, D. Dekegel, J. Ghysdael, R. Kettmann, M. Leclercq, J. Leunen, M. Mammerickx, and D. Portetelle. 1987. Bovine leukemia virus, molecular biology and epidemiology, p. 231-289 In G. Klein (ed.). Viral oncology. Raven Press. New York.
Burny, A., Y. Cleuter, R. Kettmann, M. Mammerickx, G. Marbaix, D. Portetelle, A. Van den Broeke, L. Willems, and R. Thomas. 1988. Bovine leukeima: facts and hypotheses derived from the study of an infectious cancer. Adv. Vet. Sci. Comp. Med. 32:149-161.
Gambier, J. C., and J. T. Ranson. 1987 Molecular mechanisms of transmembrane signaling in B lymphocytes. Annu Rev. Immunol. 5:175-199.
Choi, M. K., R. D. Brines, M. J. Holman, and G. G. B. Klaus, 1994. Induction of NF-AT in normal B lymphocytes by anti-immunoglobulin or CD40 ligand in conjunction with IL-4. Immunity 1:179-187.
Clipstone, N. A., and G. R. Crabtree. 1992. Identification of calcineurm as a key signalling enzyme in T-lymphocyte activation. Nature (London) 357:695-697.
Copeland, K. F. T., A. G. Haaksma, J. Goudsmit, and J. L. Heeney. 1994. Calcium-mediated inhibition of phorbol ester and Tax trans-activation of the human T cell leukaemia virus type 1. J. Gen. Virol. 75:1623-1631.
Dash, P. K., K. A. Karl, M. A. Colieos, R. Prywes, and E. R. Kandel. 1991. cAMP response element binding protein is activated by Ca2+/calmodulin- as well as cAMP-dependent protein kinase. Proc Natl. Acad. Sci. USA 88:5061-5065.
Dekker, L. V., and P. J. Parker. 1994. Protein kinase C - a question of specificity. Trends Biochem. Sci 19:73-77.
Derse, D. 1987 Bovine leukemia virus transcription is controlled by a Virus-encoded trans-acting factor and by cis-acting response elements. J Viral 61:2462-2471.
Darand, D. B., J. P. Shaw, M. R. Bush, R. E. Replogle, R. Belagaje, and G. R. Crabtree. 1988. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8:1715-1724.
Enslen, H., and T. R. Soderling. 1994. Roles of calmodulin-dependent protein kinases and phosphatase in C calcium-dependent transcription of immediate early gene. J. Biol. Chem. 269:20872-20877.
Geilen, C. C., M. Wieprecht, T. Wieder, and W. Reuttel. 1992. A selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-bromocinnamyl (amino)ethyl]-S-isoquinolinesulfonamide (H-89), inhibits phosphatidylcholine biosynthesis in HeLa cells. FEBS Lett. 309:381-384.
Giam, C., and Y. Xu. 1989. HTLV-1 tax gene product activates transcription via preexisting cellular factors and cAMP responsive element. J. Biol. Chem 264:15236-15241
Gill, D. M., and R. Meren. 1978 ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase. Proc. Natl. Acad Sci. USA 75:3050.
Glass, D. B., H.-C. Chen, L. Mende-Mueler, J. Reed, and D. A. Walsh. 1989. Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein. J. Biol. Chem. 264:8802-8810.
Gordge, P. C., and J. W. Ryves. 1994. Inhibitors of protein kinase C. Cell. Signalling 6:871-882.
Gupta, P., and J. F. Ferrer. 1982. Expression of bovine leukemia virus genome is blocked by a non-immunoglobulin protein in plasma from infected cattle Science 215:405-407.
Hama, N., F. Paliogianni, B. J. Fessler, and D. T. Boupas. 1995. Calcium/ calmodulin-dependent protein kinase II downregulates both calcineurin and protein kinase C-mediated pathways for cytokine gene transcription in human T cells. J. Exp. Med. 181:1217-1222.
Hidaka, H., Y. Sasaki, T. Tanaka, T. Endo, S. Ohno, Y. Fujii, and T. Nagata. 1981 N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation Proc. Natl Acad Sci. USA 75:4354-4357
Hoffmann, M. K. 1988. The requirement of high intracellular cyclic adenosine monophosphate concentrations distinguishes two pathways of B cell activation induced with lymphokines and antibody to immunoglobulin J. Immunol. 140:580-587
Ikeda, K., R. Okazaki, D. Inoue, E. Ogata, and T. Matsumoto. 1993. Transcription of the gene for parathyroid hormone-related peptide from the human is activated through a cAMP-dependent pathway by prostaglandin E1 in HTLV-1 infected cells. J. Biol. Chem 268:1174-1179.
Jensen, W. A., B. J. Wicks-Beard, and G. L. Cockerell. 1992. Inhibition of protein kinase C results in decreased expression of bovine leukemia virus J Virol. 66:4427-4433.
Joshi, J. B., and H. P. Dave. 1992. Transactivation of the proenkephalin gene promoter by Tax 1 protein of human T-cell lymphotropic virus type 1. Proc. Natl. Acad. Sci. USA 89:1006-1010.
Kawamoto, S., and H. Hidaka. 1984. 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets. Biochem. Biophys. Res. Commun. 125:258-264.
Kettmann, R., J. Deschamps, Y. Cleuter, D. Couez, A. Burny, and G. Marbaix. 1982. Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3′ proximate cellular sequences Proc Natl. Acad. Sci. USA 79:2465-2469.
Kobayashi, E., H. Nakano, M. Morimoto, and T. Tamaoki. 1989. Calphostin C, a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys. Res. Commun. 159:548-553
Lagarias, D. M., and K. Radke. 1989. Transcriptional activation of bovine leukemia virus in blood ceils from experimentally infected asymptomatic sheep with latent infections. J Virol. 63:2099-2107.
Lisman, J. 1989. A mechanism for the Hebb and the anti-Hebb processes underlying learning and memory. Proc. Natl Acad. Sci USA 86:9574-9578.
Mosialos, G., S. H. Hanisslan, S. Jawahar, L. Vara, E. Kieff, and T. A. Chatila. 1994. A Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, expressed after transformation of primary human B lymphocytes by Epstein-Barr virus (EBV) is induced by the EBV oncogene LMP1. J Virol 68:1697-1705.
Murphy, S. K., J. B. Lindberg, and D. A. Prussack. 1994. Alteration of phosphoinositide metabolism by attenuation of cAMP resulting from expression of the H-ras oneogene. Biochem Biophys. Res. Commun. 205:1121-1129.
Nishizuka, Y. 1984. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature (London) 308:693.
O'Keefe, S. J., J. Tamura, R. L. Kincaid, M. J. Tocci, and E. A. O'Neill. 1992. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature (London) 357:692-694.
Portetelle, D., M. Mammerickx, and A. Burny. 1989. Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukemia virus envelope protein gp51. J. Virol. Methods 23:211-222.
Randak, C., T. Brabletz, M. Hergenrother, L. Sobotta, and E. Serffing. 1990. Cyclosporin A suppresses the expression of the interleukin 2 gene by inhibiting the binding of lymphocyte-specific factors to the IL-2 enhancer. EMBO J 9:2529-2536.
Schad, C., and R. P. Phipps. 1988. Two signals are required for accessory cells to induce B cell unresponsiveness. J. Immunol. 141:79-84.
Shaw, J. P., P. J. Ule, D. B. Durand, J. J. Toole, E. A. Fmmel, and G. R. Crabtree. 1988. Identification of a putative regulator of early T cell activation genes. Science 241:202-205.
Sigal, N. H., and F. J. Dumont. 1992. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10:519-560.
Stock, N. D., and J. F. Ferrer. 1972. Replicating C-type virus in phytohem-agglutinin-treated buffy coat cultures of bovine origin. J. Natl. Cancer Inst. 48:985-996.
Tokumitsu, H., T. Chijiwa, M. Hagiwara, A. Mizutani, M. Terasawa, and H. Hidaka. 1990. KN-62, 1-[N, O-bis(5-isoquinolmesulfonyl)-N-methyl-L-tyrosyl)-4-phenylpiperazine, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II J Biol. Chem 265:4315-4320.
Venkataraman, L., D. L. Francis, Z. Wang, J. Liu, T. L. Rothstein, and R. Sen. 1994. Cyclosporin-A sensitive induction of NF-AT in murine B cells. Immunity 1:189-196.
Willems, L., A. Gegonne, G. Chen, A. Burny, R. Kettmann, and J. Ghysdael. 1987. The bovine leukemia virus p34 is a transactivator protein. EMBO J. 6:3385-3389.
Willems, L., R. Kettmann, G. Chen, D. Porteteile, A. Burny, and D. Derse. 1992. A cyclic AMP-responsive DNA-binding protein (CREB2) is a cellular transactivator of the bovine leukemia virus long terminal repeat. J. Virol. 66:766-772.
